Clinical Trials Directory

Trials / Completed

CompletedNCT04319107

Classifying Ectopia Lentis in Marfan Syndrome Into Five Grades of Increasing Severity

Status
Completed
Phase
Study type
Observational
Enrollment
110 (actual)
Sponsor
Hospices Civils de Lyon · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

Marfan syndrome is characterized by musculoskeletal manifestations, cardiovascular disease and ocular abnormalities, particularly ectopia lentis. Diagnosis depends on clinical evaluation, family history and molecular data: mutation in the fibrillin-1 gene (FBN1). Ectopia lentis is the most common ocular manifestation in Marfan syndrome with FBN1 mutation and is relatively specific to this disease when associated with other features. However, clinical examinations for identifying ectopia lentis have not really been codified. The purpose of this study is to describe a 5-grade classification of increasing severity for ectopia lentis based on clinical examination and to evaluate the predictive value for the early grades of ectopia lentis in order to help characterize this major clinical diagnosis criterion.

Conditions

Interventions

TypeNameDescription
OTHERophthalmological examinations using a slit lamp bio microscopy and a three-mirror lens, standard procedure.Pupillary dilatation was performed with instillation of tropicamide and phenylephrine. The ophthalmological examination included visual acuity measurement, using a slit lamp biomicroscopy to analyse the anterior segment and a three mirror lens to appreciate the quality of the dilation validated by the absence of pupillary reflex and to search for ectopia lentis. Ectopia Lentis grade is evaluated according to the 5-grade classification.

Timeline

Start date
2000-01-01
Primary completion
2013-12-31
Completion
2013-12-31
First posted
2020-03-24
Last updated
2020-03-27

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04319107. Inclusion in this directory is not an endorsement.